In Flemingsberg, we cure diseases that were previously considered incurable

Earlier this year we hosted the most meaningful ATMP event of the spring, in collaboration with Miltenyi Biotec and the Karolinska ATMP Center, Karolinska University Hospital and Karolinska Institutet. We gathered over 120 participants, all sharing a vision of creating momentum to accelerate access to ATMPs in the Nordics.

”It’s fantastic, it’s a great opportunity to learn more about what’s going on at Karolinska and for the whole ATMP environment. From the Pre GMP to the manufacturing, to then the clinical trials that they offer here, and I think that’s one of the things that are really unique about the whole Flemingsberg ATMP ecosystem” – Jonathan Clarke, Development Manager at SmartCella.

During the event we launched ATMP Flemingsberg, a platform that encapsulates all the expertise within ATMP in Flemingsberg, from research to clinical implementation.

”We have everything in Flemingsberg and you can see that because they come here from Uppsala and other parts of the world to manufacture their products and do their treatments here” – Ewa Ellis, ATMP coordinator at Karolinska University Hospital.

The seminar shed light on Pre-GMP and GMP, as well as how to advance one’s process to the next level and how Vecura can assist in scaling up. Additionally, Stefan Mielke, an expert in the field, discussed equal access and emphasized the importance of collaborative efforts to make therapies more accessible to patients. Di Yu from Elicera Therapeutics also shared their journey, which began at Vecura in Flemingsberg.

“Clinical trials are very important because they bring innovation to our patients. For those of you who don’t know what CAR-T cells are, they are like glasses for T-cells, so that they can see tumor cells.” – Stephan Mielke, Professor and Scientific Director of the Cancer Center.

Watch our film below, summarizing our successful event. Together, we can accelerate access to ATMPs in the Nordics.

Visit atmpflemingsberg.se

*ATMP (Advanced Therapy Medicinal Products) också kallade Avancerade terapiläkemedel är baserade på celler, vävnader eller gener och delas in i tre huvudkategorier: somatiska cellterapier, genterapier och vävnadstekniska produkter.

Bactiguard

“Previously, we had offices in central Stockholm. When we needed more space to establish an integrated facility for all our activities, including production, Flemingsberg was the natural choice. The main reason for this was proximity to Karolinska University Hospital, Karolinska Institutet, Swedish Red Cross University College, and other key partners for us. Our technology also has links with the 1912 Nobel Prize, (read more on our website), so what could be more appropriate for our new address than Alfred Nobel Allé,”

Inhalation Sciences Sweden

“In Flemingsberg, we have access to the advanced labs that we need, and it offers the right facilities we need to expand,” says Manoush Masarrat, CEO of Inhalation Sciences.

Mando Group

“We conducted our research and development in collaboration with KI and Karolinska University Hospital here in Flemingsberg – work that paved the way for our insights into what causes obesity and ultimately its treatment. The positive environment at Campus Flemingsberg encourages original thinking and collaboration and has created a stimulating environment that has been decisive for us,” says Cecilia Bergh.

Previous 787980 Next